Julien Capers
Net worth: 913 268 $ as of 2026-10-30
Net worth: 913 268 $ as of 2026-10-30
Julien E Capers worked as Corporate Counsel at CareDx, Inc., Associate General Counsel at Establishment Labs Holdings, Inc., and Assistant General Counsel at Zogenix, Inc. Education includes undergraduate studies at Stanford University and graduate studies at UC Davis School of Law.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders 0.47% | 2026-10-18 | 787,300 ( 0.47% ) | 913 268 $ | 2026-10-30 |
| Companies | Position | End |
|---|---|---|
| VERA THERAPEUTICS, INC. | General Counsel | 2025-12-31 |
| CAREDX, INC. | Corporate Officer/Principal | - |
| ESTABLISHMENT LABS HOLDINGS INC. | Corporate Officer/Principal | - |
| ZOGENIX, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UC Davis School of Law
UC Davis School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Establishment Labs Holdings, Inc.
Establishment Labs Holdings, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures medical products | Health Technology |
Vera Therapeutics, Inc.
Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions